Annual Current Liabilities
$31.62 M
+$3.64 M+13.01%
December 31, 2024
Summary
- As of March 13, 2025, CPIX annual total current liabilities is $31.62 million, with the most recent change of +$3.64 million (+13.01%) on December 31, 2024.
- During the last 3 years, CPIX annual current liabilities has risen by +$12.34 million (+64.02%).
- CPIX annual current liabilities is now at all-time high.
Performance
CPIX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$31.62 M
+$534.20 K+1.72%
December 31, 2024
Summary
- As of March 13, 2025, CPIX quarterly total current liabilities is $31.62 million, with the most recent change of +$534.20 thousand (+1.72%) on December 31, 2024.
- Over the past year, CPIX quarterly current liabilities has stayed the same.
- CPIX quarterly current liabilities is now at all-time high.
Performance
CPIX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CPIX Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +13.0% | 0.0% |
3 y3 years | +64.0% | +28.8% |
5 y5 years | +30.9% | +30.9% |
CPIX Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +64.0% | at high | +64.0% |
5 y | 5-year | at high | +64.0% | at high | +76.2% |
alltime | all time | at high | +971.7% | at high | +484.3% |
Cumberland Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $31.62 M(+13.0%) | $31.62 M(+1.7%) |
Sep 2024 | - | $31.09 M(+25.6%) |
Jun 2024 | - | $24.76 M(-6.3%) |
Mar 2024 | - | $26.43 M(-5.6%) |
Dec 2023 | $27.98 M(-2.1%) | $27.98 M(+2.4%) |
Sep 2023 | - | $27.33 M(+1.4%) |
Jun 2023 | - | $26.96 M(+4.9%) |
Mar 2023 | - | $25.71 M(-10.1%) |
Dec 2022 | $28.58 M(+48.2%) | $28.58 M(+12.9%) |
Sep 2022 | - | $25.31 M(+4.3%) |
Jun 2022 | - | $24.25 M(-1.2%) |
Mar 2022 | - | $24.56 M(+27.4%) |
Dec 2021 | $19.28 M(-24.9%) | $19.28 M(+7.4%) |
Sep 2021 | - | $17.95 M(-3.8%) |
Jun 2021 | - | $18.65 M(-18.4%) |
Mar 2021 | - | $22.85 M(-11.0%) |
Dec 2020 | $25.67 M(+6.3%) | $25.67 M(+7.2%) |
Sep 2020 | - | $23.94 M(+5.6%) |
Jun 2020 | - | $22.66 M(+17.0%) |
Mar 2020 | - | $19.37 M(-19.8%) |
Dec 2019 | $24.15 M(-13.1%) | $24.15 M(+14.7%) |
Sep 2019 | - | $21.05 M(-5.7%) |
Jun 2019 | - | $22.32 M(-20.3%) |
Mar 2019 | - | $28.00 M(+0.7%) |
Dec 2018 | $27.80 M(+57.1%) | $27.80 M(+79.2%) |
Sep 2018 | - | $15.52 M(-7.7%) |
Jun 2018 | - | $16.81 M(+3.2%) |
Mar 2018 | - | $16.29 M(-7.9%) |
Dec 2017 | $17.69 M(+19.6%) | $17.69 M(+12.0%) |
Sep 2017 | - | $15.80 M(+21.7%) |
Jun 2017 | - | $12.98 M(-7.7%) |
Mar 2017 | - | $14.07 M(-4.9%) |
Dec 2016 | $14.79 M(+19.2%) | $14.79 M(+26.6%) |
Sep 2016 | - | $11.69 M(+31.4%) |
Jun 2016 | - | $8.90 M(-20.1%) |
Mar 2016 | - | $11.14 M(-10.3%) |
Dec 2015 | $12.41 M | $12.41 M(+4.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2015 | - | $11.87 M(+2.8%) |
Jun 2015 | - | $11.55 M(-2.9%) |
Mar 2015 | - | $11.89 M(-13.5%) |
Dec 2014 | $13.75 M(+82.2%) | $13.75 M(+13.1%) |
Sep 2014 | - | $12.16 M(+2.5%) |
Jun 2014 | - | $11.86 M(+4.5%) |
Mar 2014 | - | $11.35 M(+50.4%) |
Dec 2013 | $7.55 M(-6.3%) | $7.55 M(+39.4%) |
Sep 2013 | - | $5.41 M(-11.2%) |
Jun 2013 | - | $6.09 M(-26.0%) |
Mar 2013 | - | $8.24 M(+2.2%) |
Dec 2012 | $8.06 M(+22.1%) | $8.06 M(-7.0%) |
Sep 2012 | - | $8.66 M(+21.4%) |
Jun 2012 | - | $7.13 M(+15.8%) |
Mar 2012 | - | $6.16 M(-6.7%) |
Dec 2011 | $6.60 M(-28.5%) | $6.60 M(-11.4%) |
Sep 2011 | - | $7.45 M(-30.5%) |
Jun 2011 | - | $10.73 M(+22.6%) |
Mar 2011 | - | $8.75 M(-5.1%) |
Dec 2010 | $9.23 M(-50.5%) | $9.23 M(-6.9%) |
Sep 2010 | - | $9.91 M(-35.7%) |
Jun 2010 | - | $15.43 M(-0.2%) |
Mar 2010 | - | $15.46 M(-17.0%) |
Dec 2009 | $18.62 M(+144.9%) | $18.62 M(+37.4%) |
Sep 2009 | - | $13.56 M(+70.8%) |
Jun 2009 | - | $7.94 M(+24.8%) |
Mar 2009 | - | $6.36 M(-16.4%) |
Dec 2008 | $7.61 M(-6.3%) | $7.61 M(-14.4%) |
Sep 2008 | - | $8.88 M(+1.9%) |
Jun 2008 | - | $8.71 M(-0.5%) |
Mar 2008 | - | $8.76 M(+7.9%) |
Dec 2007 | $8.12 M(-6.7%) | $8.12 M(+3.5%) |
Sep 2007 | - | $7.85 M(-8.3%) |
Jun 2007 | - | $8.55 M(+2.0%) |
Mar 2007 | - | $8.38 M(-3.6%) |
Dec 2006 | $8.70 M(+194.8%) | $8.70 M |
Dec 2005 | $2.95 M | - |
FAQ
- What is Cumberland Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual current liabilities year-on-year change?
- What is Cumberland Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly current liabilities year-on-year change?
What is Cumberland Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CPIX is $31.62 M
What is the all time high annual current liabilities for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual total current liabilities is $31.62 M
What is Cumberland Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CPIX annual total current liabilities has changed by +$3.64 M (+13.01%)
What is Cumberland Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CPIX is $31.62 M
What is the all time high quarterly current liabilities for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly total current liabilities is $31.62 M
What is Cumberland Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CPIX quarterly total current liabilities has changed by $0.00 (0.00%)